Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Pancreatic Neoplasms 2 Ketosis 1 Insulin Resistance 1 Glioma 1 Glioblastoma 1 Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Metformin 8 Surveys and Questionnaires 3 Pioglitazone 3 Nutrition Assessment 3 Methods 3 Exercise 3 Educational Status 3 Tirzepatide 2 Therapeutics 2 Tablets 2 Standard of Care 2 Specimen Handling 2 Resistance Training 2 Interviews as Topic 2 Glucose Tolerance Test 2 Biopsy 2 tocilizumab 1 tislelizumab 1 sofosbuvir-velpatasvir drug combination 1 saxagliptin 1 pembrolizumab 1 otelixizumab 1 nabiximols 1 esmolol 1 epalrestat 1 donafenib 1 dapagliflozin 1 amlodipine, atorvastatin drug combination 1 Verapamil 1 Urine Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Diabetes Mellitus × Hypoglycemic Agents × Clear all

NCT06100796 2023-10-25

NSCLC

Assiut University

Diabetes Mellitus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡